HUANG; Zhihua

Patent Applications and Registrations

Patent applications and USPTO patent grants for HUANG; Zhihua.The latest application filed is for "multispecific antigen binding proteins capable of binding cd19 and cd3, and use thereof".

Company Profile

6.19.17

HUANG; Zhihua - Shanghai CN
Huang; Zhihua - Shenzhen N/A CN
HUANG; Zhihua - Zhuhai CN
Huang; Zhihua - Guangdong CN
Huang; Zhihua - Pittsburgh PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Multispecific Antigen Binding Proteins Capable Of Binding Cd19 And Cd3, And Use Thereof App 20220064295 - HUANG; Zhihua ; et al.	2022-03-03
Faucet handle Grant D944,932 - Huang March 1, 2	2022-03-01
Sprayer head Grant D940,273 - Huang January 4, 2	2022-01-04
Movable Air Conditioner And Control Method Therefor App 20210389022 - HUANG; Zhihua ; et al.	2021-12-16
Bispecific Antigen Binding Proteins And Uses Thereof App 20210301018 - HUANG; Zhihua ; et al.	2021-09-30
Faucet Grant D912,778 - Huang March 9, 2	2021-03-09
Faucet Grant D912,776 - Huang March 9, 2	2021-03-09
Multispecific fab fusion proteins and use thereof Grant 10,870,701 - Cui , et al. December 22, 2	2020-12-22
Multispecific Fab Fusion Proteins And Use Thereof App 20190092862 - CUI; Yumin ; et al.	2019-03-28
Use of G-CSF dimer in preparation of medicament for treatment of neurodegenerative diseases Grant 9,642,917 - Wu , et al. May 9, 2	2017-05-09
Use of interleukin-22 in treating viral hepatitis Grant 9,629,898 - Yan , et al. April 25, 2	2017-04-25
Uses of interleukin-22(IL-22) in treating and preventing nerve damage diseases or neurodegenerative diseases Grant 9,352,024 - Wu , et al. May 31, 2	2016-05-31
Recombinant human G-CSF dimer and use thereof for the treatment of neurological diseases Grant 9,273,108 - Yan , et al. March 1, 2	2016-03-01
Use Of Interleukin-22 In Treating Viral Hepatitis App 20150202267 - YAN; Xiaoqiang ; et al.	2015-07-23
Uses Of Interleukin-22(il-22) In Treating And Preventing Nerve Damage Diseases Or Neurodegenerative Diseases App 20150147293 - Wu; Dongdong ; et al.	2015-05-28
Use Of G-csf Dimer In The Treatment Of Neutropenia App 20150147290 - YAN; Xiaoqiang ; et al.	2015-05-28
Use of interleukin-22 in treating viral hepatitis Grant 8,945,528 - Yan , et al. February 3, 2	2015-02-03
Use Of G-csf Dimer In Preparation Of Medicament For Treatment Of Neurodegenerative Diseases App 20140248234 - Wu; Dong-Dong ; et al.	2014-09-04
Method for identifying gambiered guangdong silk Grant 8,802,443 - Huang , et al. August 12, 2	2014-08-12
Method For Identifying Gambiered Guangdong Silk App 20140073056 - HUANG; Zhihua ; et al.	2014-03-13
Recombinant Human G-csf Dimer And Use Thereof For The Treatment Of Neurological Diseases App 20140004076 - YAN; Xiaoqiang ; et al.	2014-01-02
Recombinant human G-CSF dimer and use thereof for the treatment of neurological diseases Grant 8,557,546 - Yan , et al. October 15, 2	2013-10-15
Use Of Interleukin-22 In Treating Viral Hepatitis App 20130171100 - Yan; Xiaoqiang ; et al.	2013-07-04
Use Of G-csf Dimer In The Treatment Of Neutropenia App 20130165637 - Yan; Xiaoqiang ; et al.	2013-06-27
Recombinant Human G-csf Dimer And Use Thereof For The Treatment Of Neurological Diseases App 20110293554 - YAN; Xiaoqiang ; et al.	2011-12-01
Liquid crystal materials and electrooptic devices with a liquid crystal-containing cladding App 20060182401 - Risser; Steven M. ; et al.	2006-08-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.